Ensuring Biological Safety

The Institutional Biosafety Committee is a committee of the president that assures compliance for the biological safety aspects during the use of recombinant DNA, infectious agents (bacteria, fungi, parasites, viruses, and prions), mutagens and carcinogens, biological toxins, and biohazardous materials.

Committee

IBC Chair:  Matt Smith, Ph.D., ext. 6437

Please submit all application forms for IBC review to Trish Wilson, CRA, Regulatory Affairs Coordinator, paw@neomed.edu.

Meeting Dates

• February 27, 2024 at 11:00 a.m.
• April 30, 2024 at 11:00 a.m.
• June 25, 2024 at 11:00 a.m.
• August 27, 2024 at 11:00 a.m.
• October 29, 2024 at 11:00 a.m.
• December 10, 2024 at 11:00 a.m.

All NEOMED Biosafety Committee meetings are open to the public.  To attend a meeting, please contact the committee coordinator, Trish Wilson, at paw@neomed.edu.